Clinical practice. Screening for colorectal cancer.

Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA (2006) 4.34

Antagonist: population based endoscopic screening for colorectal cancer. Gut (2003) 1.51

Colonoscopic screening for colorectal cancer improves quality of life measures: a population-based screening study. Health Qual Life Outcomes (2006) 1.12

Registered nurse-performed flexible sigmoidoscopy in Ontario: development and implementaton of the curriculum and program. Can J Gastroenterol Hepatol (2014) 1.04

Predictors of endoscopy in minority women. J Natl Med Assoc (2005) 1.03

Current status of CT colonography. Acad Radiol (2006) 1.00

Understanding factors related to Colorectal Cancer (CRC) screening among urban Hispanics: use of focus group methodology. J Cancer Educ (2010) 0.96

Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans. Ethn Dis (2009) 0.96

Colorectal cancer screening in Vietnamese Americans. J Cancer Educ (2008) 0.96

Assessing endoscopic colorectal screening adherence in an emergency department population. J Natl Med Assoc (2006) 0.94

Using focus groups to develop interventions to promote colorectal cancer screening among Vietnamese Americans. J Cancer Educ (2006) 0.93

Detection of early colorectal cancer development in the azoxymethane rat carcinogenesis model with Fourier domain low coherence interferometry. Biomed Opt Express (2010) 0.89

Effect of comorbid conditions on adherence to colorectal cancer screening. J Cancer Educ (2012) 0.89

Is the distal hyperplastic polyp a marker for proximal neoplasia? J Gen Intern Med (2003) 0.86

Transferred and delayed care of patients with colorectal cancer in a safety-net hospital system--manifestations of a distressed healthcare system. J Gen Intern Med (2012) 0.84

Screening colonoscopy in the asymptomatic 50- to 59-year-old population. Surg Endosc (2003) 0.82

Incidence of advanced adenomas of the rectosigmoid colon three years and five years after negative flexible sigmoidoscopy in 4010 patients. Dig Dis Sci (2003) 0.81

CT colonography: an update. Eur Radiol (2007) 0.81

Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther (2014) 0.81

Surgeon-initiated screening colonoscopy program based on SAGES and ASCRS recommendations in a general surgery practice. Surg Endosc (2006) 0.80

Effects of the addition of high-dose vitamin C to polyethylene glycol solution for colonic cleansing: A pilot study in healthy volunteers. Curr Ther Res Clin Exp (2005) 0.76

Comparison of a 4-Day versus 2-Day Low Fiber Diet Regimen in Barium Tagging CT Colonography in Incomplete Colonoscopy Patients. Gastroenterol Res Pract (2015) 0.75

Screening for colorectal cancer. N Engl J Med (2002) 0.75

How to identify the genetic basis of gastrointestinal and liver diseases? Gut (2003) 0.75

Screening for colorectal cancer. N Engl J Med (2002) 0.75

Are proximal colorectal cancers always associated with distal adenomas? Gut (2003) 0.75

Screening for colorectal cancer. N Engl J Med (2002) 0.75

Colonoscopy vs CT colonography to screen for colorectal neoplasia in average-risk patients. Surg Endosc (2005) 0.75

Impact of adenoma size in distal colon on risk for advanced adenoma of the proximal colon. Dig Dis Sci (2006) 0.75

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46

A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93

Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15

Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02

Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer (2004) 4.73

Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer (2005) 4.43

Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79

Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology (2006) 3.35

Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol (2013) 3.31

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst (2009) 3.15

A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology (2011) 3.03

Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94

The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med (2015) 2.88

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet (2008) 2.83

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 2.80

A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy. Am J Gastroenterol (2002) 2.75

Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70

Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst (2009) 2.64

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43

RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest (2007) 2.25

Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis (2012) 2.23

KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Mol Cancer Ther (2009) 2.22

Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14

A causal association between isotretinoin and inflammatory bowel disease has yet to be established. Am J Gastroenterol (2009) 2.14

Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13

Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol (2010) 2.10

Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol (2003) 2.06

Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology (2012) 1.97

Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol (2013) 1.83

Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst (2003) 1.80

Patient time requirements for screening colonoscopy. Am J Gastroenterol (2007) 1.74

Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst (2007) 1.73

Editorial: colonoscopy and colorectal cancer mortality: strong beliefs or strong facts? Am J Gastroenterol (2010) 1.71

Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol (2013) 1.71

Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol (2008) 1.71

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology (2003) 1.70

Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut (2011) 1.70

Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology (2004) 1.70

Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci (2010) 1.68

Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst (2004) 1.67

Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66

Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J (2012) 1.62

Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2005) 1.52

Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl (2002) 1.52

Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol (2005) 1.49

Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev (2002) 1.48

Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg (2010) 1.48

Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol (2016) 1.47

Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2005) 1.45

Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study. Med Decis Making (2008) 1.45

Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev (2004) 1.45

Research recruitment through US central cancer registries: balancing privacy and scientific issues. Am J Public Health (2006) 1.37

Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care (2013) 1.36

Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33

Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev (2005) 1.31

Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31

Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2003) 1.29

Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci (2012) 1.27

Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer (2006) 1.22

Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured. Clin Gastroenterol Hepatol (2011) 1.21

Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology (2006) 1.21

Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. Gastroenterology (2002) 1.20

Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis (2011) 1.17

Rural-urban differences in colon cancer risk in blacks and whites: the North Carolina Colon Cancer Study. J Rural Health (2006) 1.16

Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol (2003) 1.16

Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol (2007) 1.16

Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res (2010) 1.15

Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev (2005) 1.13

Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol (2006) 1.13

A diet high in fruits and low in meats reduces the risk of colorectal adenomas. J Nutr (2007) 1.11

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst (2006) 1.11

Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer (2004) 1.11

Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev (2002) 1.10

Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis (2008) 1.10

The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev (2009) 1.10

Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol (2008) 1.06

Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev (2010) 1.06

Dietary patterns, food groups, and rectal cancer risk in Whites and African-Americans. Cancer Epidemiol Biomarkers Prev (2009) 1.05

Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol (2007) 1.05

UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutat Res (2008) 1.05

Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am J Epidemiol (2010) 1.05

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst (2009) 1.05

Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf (2013) 1.05

Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev (2008) 1.05

Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.04

The association of physical activity and body mass index with the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev (2005) 1.04

Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners). Inflamm Bowel Dis (2014) 1.03

Quality of colonoscopy reporting: a process of care study. Am J Gastroenterol (2002) 1.03

Gastrointestinal endoscopy nurse experience and polyp detection during screening colonoscopy. Clin Gastroenterol Hepatol (2008) 1.03

Patient perspectives on research recruitment through cancer registries. Cancer Causes Control (2005) 1.02

Race and colorectal cancer screening: a population-based study in North Carolina. N C Med J (2004) 1.02

Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control (2012) 1.02

COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States). Cancer Causes Control (2006) 1.01

Health behavior correlates among colon cancer survivors: NC STRIDES baseline results. Am J Health Behav (2006) 1.00

Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol (2013) 1.00